Luminex (LMNX) Solid Merits; Sanmina (SANM) Growth Above Forecasts

Luminex_LMNX

Shares of Luminex Corporation (Nasdaq:LMNX) soared more than 10% to touch a new 52-week high in the extended session Monday after the company reported stronger-than-expected quarterly financial results and surpassing the $60 million mark in revenue for the first time in the company’s history

For the third quarter 2015, Luminex posted revenue of $60.6 million and non-GAAP (excluding non-recurring items) net income of $9.26 million, or $0.22 per diluted share, exceeding the Capital IQ Consensus estimate of $0.12 earnings per share on revenues of $57.24 million for the period

LMNX stock closed the regular session at $19.24, up $1.04 (or +5.71%), with a total volume of 534,646 shares traded during the day.

Luminex, which develops, manufactures and markets proprietary biological testing technologies, has 43.05M Shares Outstanding, Market Capitalization (intraday) of $828.23M and LMNX stock 52-week range is between $15.05 and $21.16 per share

*

Sanmina_SANM

Sanmina Corporation (Nasdaq:SANM) shares surged $0.30 (or +1.45%) to $20.97 on Monday’s market activity

Sanmina delivered solid financial performance in its quarterly earnings report as a result of the company’s focus on executing its core strategy

For its fourth quarter fiscal 2015, Sanmina posted revenue of $1.64 billion and non-GAAP net income of $47.7 million, or $0.57 per diluted share, topping the Capital IQ Consensus estimate of $0.54 earnings per share on revenues of $1.6 billion for the period

SANM stock climbed over 10% in after-hours trading following the release of the company’s financial statement

Sanmina, a leading integrated manufacturing solutions provider, has 80.46M Shares Outstanding, Market Capitalization (intraday) of $1.69B and SANM stock one-year range is $17.55 – $26.08 per share

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/